Melanoma trials in France

In France 61 Also abroad 578

61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
Where
Marseille
People
100 worldwide
Run by
Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT06605417
No phaseTaking people
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
Where
Amiens, Annecy, Besançon, Bobigny, Bordeaux, Boulogne-Billancourt, Brest, Caen, Créteil, Dijon, Grenoble, Lille, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Nîmes, Paris, Rennes, Toulouse
Age
18 years and over
People
6,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT02828202
No phaseTaking people
Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Where
Bron, Grenoble, Lyon, Pierre-Bénite, Saint-Etienne
Age
18 years and over
People
100
Run by
Hospices Civils de Lyon
See details and how to joinNCT04605146
No phaseTaking people
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Where
Lille, Villejuif
Age
18 years and over
People
200 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767
No phaseTaking people
Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors
Where
Lille, Montpellier, Nice
Age
18 years and over
People
60
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT05649683
Phase 2Taking people
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Where
Lille, Paris
Age
18 years and over
People
60 worldwide
Run by
IO Biotech
See details and how to joinNCT05280314
No phaseTaking people
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
Where
Grenoble
Age
18 years and over
People
707
Run by
University Hospital, Grenoble
See details and how to joinNCT06154668
No phaseTaking people
Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients
Where
Lyon
Age
18 years and over
People
100
Run by
Hospices Civils de Lyon
See details and how to joinNCT05029791
No phaseTaking people
Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients
Where
Créteil
Age
70 years and over
People
303
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05794035
No phaseTaking people
Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma
Where
Pierre-Bénite
Age
18 years and over
People
1,000
Run by
Hospices Civils de Lyon
See details and how to joinNCT05527795
No phaseTaking people
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Where
Bron, Lyon, Pierre-Bénite
Age
18 years and over
People
410
Run by
Hospices Civils de Lyon
See details and how to joinNCT03787056